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บทคดัยอ่  
วตัถปุระสงค:์ เพื่อทดสอบสารสกดัจากนมผึง้ต่อการเพิม่จาํนวนเซลลแ์ละผลต่อ
การสรา้งเซลล์กระดูกในเซลล์ 3 ชนิด คอื เซลล์ไฟโบรบลาสต์จากเน้ือเยื่อเหงอืก
มนุษย ์(HGF) จากเอน็ยดึปรทินัต ์(HPDL) และเซลลก์ระดูกสะโพกมนุษย ์(HIP) 
วิธีการศึกษา: ทดสอบผลของสารสกดันมผึง้ (ความเขม้ขน้ 0.1, 0.5, 1, 5 และ 
10 มก./มล.) ต่อการมชีวีติของเซลล์ด้วยวธิ ี(3-(4,5 ไดเมท็ธลิไทอะซอล-2-อลิ)-
2,5-ไดเฟนิลเตตระโซเลยีมโบรไมด์ (MTT) ศกึษาการเพิม่จาํนวนเซลล์ในช่วง 6 
วนัดว้ยวธิซีลัโฟโรดามนิบ ี(SRB) และวดัระดบัการทาํงานของสารอลัคาไลน์ฟอส
ฟาเตส (ALP) เพือ่วดัการตอบสนองของเซลลท์ัง้ 3 ชนิดต่อสารสกดัจากนมผึง้โดย
การเพาะเลีย้งเป็นเวลา 14 วนั ผลการศึกษา: สารสกดันมผึง้เขม้ขน้ 10 มก./มล.
เป็นพษิต่อ HGF และ HPDL แต่ไม่พบฤทธิด์งักล่าวต่อ HIP สารสกดันมผึง้ยบัยัง้
การเพิม่จาํนวนเซลล ์HGF และ HPDL ที ่5 มก./มล. โดยทีค่วามเขม้ขน้ตํ่ากว่าน้ี
กระตุน้การเพิม่จาํนวนเซลล์ดงักล่าวไดเ้ลก็น้อย ในทางกลบักนัพบว่าสารสกดันม
ผึง้ทกุความเขม้ขน้ไม่เพิม่จาํนวนเซลล ์HIP ในเซลล ์HPDLและ HIP ทีเ่ตมิและไม่
เติมสารสกดันมผึ้งพบการว่าการทํางานของอลัคาไลน์ฟอสฟาเตสถูกกระตุ้นใน 
HIP ทีค่วามเขม้ขน้ของสารสกดันมผึง้ 5 มก./มล. โดยไม่มผีลต่อ HPDL สรปุ: 
พบผลของสารสกดัจากนมผึ้งทีแ่ตกต่างกนัในด้านการกระตุ้นการเพิม่จํานวนใน
เซลล์ 3 ชนิด โดยพบทศิทางที่ดีของสารสกดัจากนมผึ้งที่ให้ผลบวกต่อการเพิม่
จํานวนและการเพิม่การทํางานของสารอลัคาไลน์ฟอสฟาเตสในเซลล์กระดูก ซึ่ง
สง่ผลดสีาํหรบัความตอ้งการกระตุน้ใหส้รา้งกระดูกในการรกัษาโรคปรทินัตอ์กัเสบ
หรอืโรคอื่น ๆ ทีพ่บการทาํลายกระดกู  
คาํสําคญั: สารสกดัจากนมผึ้ง, เซลล์ไฟโบรบลาสต์จากเน้ือเยื่อเหงือกมนุษย์,       
เซลล์ไฟโบรบลาสต์จากเอน็ยดึปรทินัต์, เซลล์กระดูกมนุษย์, ความ
เป็นพษิต่อเซลล ์ 
 
Abstract 
Objective: To study the in vitro effect of royal jelly crude extraction (RJCE)  
on proliferation and osteoblastic activity in 3 cell types which were human 
gingival fibroblasts (HGF), human periodontal ligament fibroblasts (HPDL) 
and human hip bone cells (HIP). Method: This study used 24-hour (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cytotoxic 
assay, sulforhodamin B (SRB) proliferation assay and alkaline phosphatase 
activity (ALP) assay to evaluate the responses of these three cell types to 
the RJCE (concentrations of 0.1, 0.5, 1, 5 and 10 mg/ml) after 14-day 
culture. Results: It was found that RJCE was cytotoxic to HGF and HPDL 
at 10 mg/ml, but no cytotoxicity to HIP. From a 6-day-proliferation assay, 
RJCE showed proliferation inhibition to HGF and HPDL at 5 mg/ml, 
however, slight proliferation stimulation was observed with lower doses. On 
the contrary, HIP showed no proliferation response to RJCE for all dosages 
used up to 5 mg/ml. Stimulation on alkaline phosphatase (ALP) activity for 
HPDL and HIP with or without RJCE after 14-day culture was found only in 
HIP at 5 mg/ml RJCE, and not in HPDL. Conclusion: this present study 
showed different effect of RJCE on the 3 cell lines proliferation. The 
positive effect on bone cell proliferation and ALP activity looks promising for 
bone regeneration as needed for periodontal disease as well as other bone 
pathology.  
Keywords: royal jelly, human gingival fibroblasts, human periodontal 
ligament fibroblasts, human hip bone cells, cytotoxicity  
 
Introduction
In recent years, natural products have been widely used 
as health promoting agents. Part of the reasons was due to 
its “natural origin,” which to most people, seems to be safer 
when compared to chemical agents. Moreover, for the 
products made from local ingredients, their costs would be 
more affordable to most consumers. Royal jelly (RJ) is a 
product from bee industry in the northern part of Thailand. It 
is produced in the hypopharyngeal and mandibular gland of 
worker honeybees, Apis Mellifera, as an exclusive food for 
the queen bee.3 Chemically, RJ comprises of approximately 
50 - 60% water, 18% protein, 15% carbohydrate, 3 - 6% 
lipid, and small amount of mineral salts and vitamins.3 
Previous studies reported that RJ exhibited numerous 
physiological and pharmacological effects including anti-
inflammatory11,12, antihypercholesterolemic3, estrogenic14 and 
anti-allergic activities15,20 and augmentation of wound 
healing.16,21,27 However, studies on effects of RJ on oral cells 
are still limited.16 
It was previously reported that RJ stimulated as well as 
inhibited growth of many cell types.1,2,4,5,13,14 It was found to 
stimulate proliferation of human myeloid cell line7, MCF-7 
breast cancer cell line5,14, human monocyte19, Tn-5Ba-4 
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insect cells13 and primary rat hepatocyte.18 At the same time 
there were reports on inhibitory activity of RJ on 
macrophage-like UM cells and human myeloid cell line.7 
Moreover RJ inhibited effect of Bisphenol A simulation of 
MCF-7 breast cancer cell line.4 
Periodontium refers to tissues that surround and support 
the teeth. It consists of gingiva, periodontal ligament, 
alveolar bone and cementum. Periodontal disease is an 
inflammatory disease that affects the periodontium. It is 
caused by microorganism along with an overly aggressive 
immune system. Periodontal disease results in destruction of 
periodontium and, in the end, a loss of the tooth from its 
socket. The ability of the periodontal cells to repair the tissue 
is very crucial and many attempts had been made in order to 
restore lost periodontium.1 This process, however, could not 
be easily achieved. It requires a series of different cell types, 
among which gingival fibroblasts, periodontal ligament 
fibroblasts, osteoblasts, endothelial cells and cementoblast. 
Cell proliferation is an initial step for wound healing 
process. In the present study, we studied the effect of royal 
jelly crude extract (RJCE) on proliferation of human gingival 
fibroblasts (HGF), human periodontal ligament fibroblasts 
(HPDL) and human hip bone cell (HIP). We also analyzed its 
effect on alkaline phosphatase activity, an enzyme 
associated with bone formation.8,24,25 The findings could be 
beneficial for further development of an agent to promote 
healing of oral wound as well as the periodontium.  
  
Materials and Methods 
Cell Culture and Reagents 
Human gingival and periodontal ligament fibroblasts 
(HGF and HPDL) were obtained from caries-free third molars 
extracted for orthodontic reasons at the Faculty of Dentistry, 
Srinakharinwirot University with the patients’ informed 
consent. The teeth were washed with sterile phosphate 
buffer saline (PBS) several times. The gingival tissues were 
gently removed from cervical area and the periodontal 
tissues were scraped from middle third of the roots by sterile 
surgical blades. Human primary hip bone cells (HIP), under 
the patients’ informed consent, were a kind gift from Dr. 
Weerachai Singhatanadgit, Faculty of Dentistry, Thammasat 
University. HGF and HPDL were cultivated in Dulbecco’s 
modified eagle medium (DMEM). HIP was cultivated in α-
minimum essential medium (α-MEM). All the media were 
supplemented with 10% fetal calf serum (10% FCS-DMEM 
and 10% FCS-α-MEM), 2 mM L-glutamine, 100 IU/ml 
penicillin G, and 100 IU/ml streptomycin. Cultures were 
maintained at 37 °C in 5% CO2. The medium and all 
supplements were from Gibco BRL (Carlsbad, CA, USA). 
HGF and HPDL were prepared from 3 teeth obtained from 3 
donors and cells from passage 3 - 8 were used in the 
experiments. This study was approved by the Research 
Ethic Committee, Faculty of Dentistry, Srinakharinwirot 
University.  
 
RJCE Preparation  
Royal jelly, Apis mellifera, was purchased from Supa 
Farm, Chiang Mai, Thailand. They were stored at -20°C until 
used. Throughout the study we used the same lot to avoid 
variations of this natural product. RJ components were 
extracted with sterile PBS at a stock concentration of 50 
mg/ml for 1 hour on rotation wheel. RJCE was recovered by 
centrifugation at 15,000 RPM for 10 min. at 4 °C. Only the 
supernatant was filtered and kept for experiment. RJCE was 
freshly prepared for each experiment. The RJCE protein 
profile was determined by 10% sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis (10% SDS-PAGE) and 
coomasie blue staining. RJCE showed a major protein band 
at 55 kDa (as showed in Fig. 1) and minor bands at 49, 60, 
and 70 kDa. At the beginning, we varied concentrations from 
10 to 80 mg/ml of royal jelly and found the highest amount of 
protein band at 50 mg/ml. Based on this finding, we used 50 
mg/ml for a stock concentration for all experiments.  
   
          MW    RJCE Figure 1 SDS-PAGE profile of royal 
jelly proteins stained with 
coomassie blue.   
Note: MW = molecular weight 
marker; RJCE = royal jelly crude 
extraction  
 
 
 
Another concern about royal jelly was its acidic pH. The 
RJCE was found to have a pH of about 3. However, buffered 
capacity of the culture media helped to neutralize it to pH 8 
(for control, 0.1, 1 and 5 mg/ml) and to pH 7.5 at 10 mg/ml. 
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Cytotoxicity Test by MTT Assay  
In order to find the appropriate doses of RJCE, 24-hour 
cytotoxicity of RJCE to HGF, HPDL and HIP was performed 
using MTT assay. Cells (10,000 per well) were plated in 96-
well plates in 10% FCS-DMEM or 10% FCS-α-MEM 
overnight to allow attachment. The next day, wells were 
washed 3 times with media and changed to serum-free 
DMEM (SF-DMEM) or α-MEM (SF-α-MEM). RJCEs were 
treated to the cells at 0.1, 0.5, 1, 5 and 10 mg/ml (5 wells 
per treatment) for another 24 hours. PBS was used as a 
negative control. At the end of the experiment, media were 
changed to fresh DMEM or α-MEM (100 μl per well). Ten 
μL of MTT solution (5 mg/ml in PBS) was added to each 
well and incubated for an additional 30 min. at 37°C 5% 
CO2. The colored formazan product was then dissolved in 
100 μL of DMSO and optical density read at 550 nm. Mean 
optical density of the control group was adjusted to 100 cell 
percentage; consequently cell numbers of treatment 
conditions were also adjusted.   
 
Proliferation Assay by SRB Method 
Cells (1,000 per well) were plated in 96-well plates in 
10% FCS-DMEM or 10% FCS-α-MEM overnight to allow 
attachment. The next day, the media were replaced with 
DMEM or α-MEM supplemented with 2.5% fetal calf serum 
(2.5% FCS-DMEM or 2.5% FCS-α-MEM). RJCEs were 
treated to the cells at 0.1, 0.5, 1 and 5 mg/ml (5 wells per 
treatment). PBS was used as a negative control. Each day 
one plate of each cell type was fixed with 25 ul/well of cold 
50% (w/v) trichloroacetic acid (TCA, Sigma) for 1 hour at 4 
°C. The conditioned media were then discarded, and plates 
were washed 5 times with distilled water and air-dried. After 
day 6, all plates were stained with 0.4% w/v sulforhodamine 
B solution (SRB) in 1% acetic acid (100 µl per well) (Sigma), 
and incubated for 10 min. at room temperature with gentle 
shaking. Unbound SRB was removed by washing 5 times 
with 1% acetic acid and the plates were then air-dried. 
Bound stained were solubilized with 10 mM Tris-buffered 
saline and the optical densities were read at 490 nm. Mean 
optical density of the control group was adjusted to 100 cell 
percentage; consequently cell numbers of treatment 
conditions were also adjusted.   
 
 
Alkaline Phosphatase Assay 
Cells (30,000 per well) were plated in 24-well plates and 
allow for attachment for 2 nights. The media were changed 
to osteogenic media which were 2.5% FCS-DMEM or α-
MEM supplemented with 50 ug/ml ascorbic acid, 5 mM β-
glycerophosphate and 250 nM dexamethasone in ethanol. 
RJCEs were treated to the cells at 0.5, 1 and 5 mg/ml (5 
wells per treatment). PBS was used as a negative control. 
The osteogenic media and RJCE were changed every 2-3 
days and the culture was maintained for a period of 14 days.  
At the end of the experiment, alkaline phosphatase (ALP) 
activity was determined qualitatively and quantitatively. For 
qualitative assays, cells were washed 3 times with PBS and 
fixed with 70% ethanol for 10 min. The cells were then 
incubated for 30 min. with 5-bromo-4-chloro-3-indolyl 
phosphate/nitro blue tetrazolium (BCIP/NBT) liquid substrate 
(Sigma) at 37 °C. The reaction was stopped by removing the 
substrate solution and washed with distilled water. ALP-
positive cells were visualized by their dark blue color.   
The ALP quantitative assay was modified from Pavasant 
et al.27 Cells were rinsed twice with PBS and scraped in 120 
μl of alkaline lysis buffer (10 mM Tris–HCl, 2 mM MgCl2, 
0.1% Triton-X 100, pH 10). The amount of 100 μl of each 
sample was incubated in the buffer containing 2 mg/ml p-
nitrophenol phosphate (pNPP) in 0.1 M 2-amino-2-methyl-1-
propanol, 2 mM MgCl2, pH 10.5 at 37 °C. To stop the 
reaction, 0.9 ml of 0.1 M NaOH was added to each well and 
the absorbance was measured at 410 nm. The other 20 μl of 
each sample was used for protein quantitation using BCA 
protein assay kit (Thermo Scientific, USA) with bovine serum 
albumin as a standard. ALP activity was calculated as 
nanomolar of p-nitrophenol/μg protein/min and then adjusted 
into percentage of expression.    
 
Statistical Analysis 
Responses among different RJCE concentrations were 
statistically tested using one-way analysis of variance 
(ANOVA) with Scheffe’s test for multiple pair-wise 
comparisons. Statistical significance was set at P < 0.05.   
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Results 
 
Cytotoxicity of RJCE to HGF, HPDL and HIP   
Toxicity of RJCE based on MTT assay is shown in Fig. 
2. The results for HGF and HPDL showed similar pattern 
where RJCE at 10 mg/ml was cytotoxic to both cell lines. 
The cell numbers dropped to 54.58% and 84.1% when 
compared to the controls for HGF and HPDL respectively (P 
< 0.05). On the contrary, at 0.1 – 5 mg/ml, RJCE showed a 
slight up-regulation of the cells numbers, which was found 
statistically significant at 1 and 5 mg/ml RJCE in HPDL (P < 
0.05).  
 
2A) Cytotoxicity of RJCE to HGF 
 
2B) Cytotoxicity of RJCE to HPDL 
 
2C) Cytotoxicity of RJCE to HIP 
 
 
Figure 2 Twenty-four-hour cytotoxic assay of royal jelly 
concentrate extract (RJCE) to human gingival 
fibroblast (HGF) (2A), human periodontal ligament 
fibroblasts (HPDL) (2B) and human primary hip bone 
cells (HIP) (2C).   
 Note: Cells (10,000 per well in 96-well-plates) were plated overnight. The 
next day, media were changed to SF-DMEM or SF-α-MEM 100 μl per well. 
RJCE were treated to the cells at 0.1, 0.5, 1, 5 and 10 mg/ml (5 wells per 
treatment). PBS was used as a control. After 24 hour, cytotoxicity was 
determined using MTT assay.  
 
For HIP cells, however, the cells seemed to be more 
tolerant to the RJCE treatment than the other two fibroblast 
lines. The HIP cell numbers in each of all treatment doses 
remained the same as compared to the control group (Fig. 
2C). Based on these findings, we decided to use RJCE with 
the maximum dose of 5 mg/ml for all cell types, for the rest 
of the experiment. 
 
RJCE Effect on HGF, HPDL and HIP Cell Proliferation 
To examine the longer effect of RJCE on the 3 cell lines, 
we grew the cells for up to 6 days in the presence of 0, 0.1, 
0.5, 1 and 5 mg/ml of RJCE and performed SRB-proliferation 
assay. As shown in Figure 3 for day 6, the results of the 3 
lines were in agreement with the cytotoxic assay. For HGF 
and HPDL, RJCE at 5 mg/ml significantly inhibited cell 
proliferation (p<0.05) whereas for the lower doses (0.1, 0.5 
and 1 mg/ml) of RJCE, slight proliferation stimulation was 
observed. The HIP line, again, showed no proliferation 
inhibition by RJCE. Besides, slight proliferation stimulation 
was seen. 
 
3A) HGF 
 
3B) HPDL 
 
3C) HIP 
 
   
Figure 3 Proliferation assay of RJCE to HGF (3A), HPDLF 
(3B) and HIP (3C).  
 Note: Cells (1,000 per well in 96-well-plate) were plated overnight. The 
next day, the media were replaced with 2.5%-FCS DMEM or 2.5%-α-
MEM. RJCE were treated at 0.1, 0.5, 1 and 5 mg/ml (5 wells per 
treatment). PBS was used as a negative control. Each day, plate was 
fixed with 50% TCA. At the end of the experiment, plates were stained 
with 0.4% w/v SRB in 1% acetic acid. Bound stained were solubilized with 
10 mM Tris-buffered saline and the OD read at 490 nm.  Shown here are 
the results of day 6.  
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Alkaline Phosphatase Assay of RJCE Treated HPDL 
and HIP 
As previously reported9 HPDL has the osteogenic 
potencial and the ability to produce osteogenic marker such 
as alkaline phosphatase enzyme when stimulated with 
osteogenic media. We then treated HPDL and HIP with 0.5, 
1 and 5 mg/ml RJCE along with the osteogenic media for 14 
days. It was found that both lines were able to produce 
alkaline phosphatase as determined by dark blue staining of 
5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium 
(BCIP/NBT) liquid substrate (data not shown) as well as 
quantitative analysis by pNPP substrate (Fig. 4). ALP 
quantitative assay revealed no difference for ALP production 
with RJCE treatment in HPDL (Fig. 4A). However, RJCE at 5 
mg/ml was able to induce ALP activity up to 148.35% in HIP 
cell lines (Fig. 4B) (P < 0.05).  
 
4A) HPDL 
 
4B) HIP 
 
 
Figure 4 Alkaline phosphatase (ALP) quantitative analysis by 
PNPP substrate: HPDL (4A), and HIP (4B).  
 
Discussions and Conclusion 
Royal jelly (RJ) is composed of protein, carbohydrate, 
lipid and mineral salt.3,22 The crude protein extract of RJ 
consists of both water-soluble and water-insoluble proteins. 
The water-soluble proteins, which we used in this study, 
make up 46 - 89% of the total RJ proteins.22 As shown in 
Figure. 1, the protein bands between 47 - 80 kDa belong to 
one protein family designated as major royal jelly proteins 
(MRJP). To date, 5 members of this family, MRJP 1 - 5, 
have been identified.22  
Periodontal ligament cells comprise of cells that 
potentially differentiate into various cell types including 
fibroblasts, osteoblasts and cementoblasts.9 In vitro study 
found the ability of HPDL cells to differentiate to hard tissue 
forming cell once cultured under appropriate environment.9 
When compared to human HGF, HPDL exhibited 
characteristics significantly distinct by producing more protein 
and collagen as well as higher expression of alkaline 
phosphatase.10 The latter property was suggestive of a more 
“osteoblast-like” character of HPDL to HGF. Interestingly, the 
unique characteristics of each cell type were also reflected in 
differences of their response to RJCE. For both fibroblast 
lines, HGF and HPDL, RJCE inhibited proliferation at a high 
dose (5 mg/ml). For lower doses, RJCE up to 1 mg/ml was 
able to stimulate HPDL proliferation, whereas the stimulatory 
effect reclined at above 0.1 mg/ml for HGF. 
Our finding of HIP bone cell as the most tolerant one to 
high doses of RJCE as compared to HGF and HPDL is 
interesting and in agreement with previous reports on 
positive effects of RJ on bone.2,6 It was found that RJ 
stimulated proliferation of mouse osteoblast-like MC3T3-E1 
cells as well as enhanced collagen production in its cultured 
medium.2 RJ also prevented the development of 
osteoporosis in experimental rats induced by ovariectomy.6 
The stimulatory effect of RJ to bone cells as reported by 
others2,6 corresponded to our finding in terms of the bone 
cell proliferation. In bone cells, there was no inhibitory effect 
of RJCE. Moreover, stimulation of ALP activity in HIP bone 
cell was also found. This point of view supports the positive 
effect of RJ to regain bone. Clinically, surgical bone graft 
seems to be the choice at the moment. The result from this 
study along with many other ongoing studies may potentially 
lead to novel regenerative therapies for bone tissue.30 
Taken together, this present study showed different 
proliferative responses of the 3 cell lines to RJCE and an 
ALP stimulatory effect in HIP bone cells. Further studies of 
RJ effect on alveolar bone cells and cementoblasts would be 
required. Also, clarification of the components of RJ which 
possess this effect along with other behavior e.g. cell 
adhesion, migration, collagen production would lead to a 
more complete picture of the effect of RJ on cells. 
Considering its availability and possibly positive effect on the 
periodontium, RJ seems to be an interesting agent in 
dentistry. However, awareness should be taken as RJ 
consumption has been linked with allergic reaction such as 
contact dermatitis, asthma and even anaphylaxis.23 Another 
issue to keep in mind is that, being a natural product, 
seasonal variations could affect its chemical composition.28 A 
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thorough knowledge as well as quality manufacture is crucial 
for achieving an effective usage of this natural product. 
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